Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
498
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
+3.2M
-
Total reported value, excl. options
-
$15.7B
-
Value change
-
+$286M
-
Put/Call ratio
-
0.63
-
Number of buys
-
216
-
Number of sells
-
-254
-
Price
-
$88.48
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q3 2023
627 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q3 2023.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 498 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
of 192M outstanding shares and own 92.48% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (18.4M shares), VANGUARD GROUP INC (17.7M shares), BlackRock Inc. (14.6M shares), Dodge & Cox (14.2M shares), STATE STREET CORP (6.46M shares), Capital Research Global Investors (6.02M shares), BARCLAYS PLC (5.57M shares), AMERIPRISE FINANCIAL INC (5.16M shares), VIKING GLOBAL INVESTORS LP (4.22M shares), and Avoro Capital Advisors LLC (3.85M shares).
This table shows the top 498 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.